0001628804-17-000002.txt : 20170526
0001628804-17-000002.hdr.sgml : 20170526
20170526160602
ACCESSION NUMBER: 0001628804-17-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170526
DATE AS OF CHANGE: 20170526
EFFECTIVENESS DATE: 20170526
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Next Frontier Biosciences, LLC
CENTRAL INDEX KEY: 0001628804
IRS NUMBER: 464797759
STATE OF INCORPORATION: CO
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-284036
FILM NUMBER: 17873968
BUSINESS ADDRESS:
STREET 1: 4156 15TH STREET
CITY: BOULDER
STATE: CO
ZIP: 80304
BUSINESS PHONE: 303-550-3133
MAIL ADDRESS:
STREET 1: 4156 15TH STREET
CITY: BOULDER
STATE: CO
ZIP: 80304
FORMER COMPANY:
FORMER CONFORMED NAME: TM Delivery Systems, LLC
DATE OF NAME CHANGE: 20141222
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001628804
Next Frontier Biosciences, LLC
4156 15TH STREET
BOULDER
CO
COLORADO
80304
303-550-3133
COLORADO
TM Delivery Systems, LLC
Limited Liability Company
true
2014
Marc
Graboyes
4156 15th Street
Boulder
CO
COLORADO
80304
Executive Officer
Director
President, Chief Executive Officer, Treasurer and Secretary
Paul
Johnson
12020 211th Place SE
Snohomish
WA
WASHINGTON
98296
Executive Officer
Director
Executive Vice President, Chief Scientific Officer
Other Health Care
Decline to Disclose
- 06b
true
0001628804-17-000001
2017-03-20
false
true
false
0
Norman Jones
6322035
LoHi Securities
36402
c/o Catalyst Partners, LLC
700 Louisiana Street, Suite 3950
Houston
TX
TEXAS
77002
CA
CALIFORNIA
CO
COLORADO
NM
NEW MEXICO
NY
NEW YORK
TX
TEXAS
false
3000000
1785119
1214881
Offer and Sale of Series A Preferred Units and Conversion of Simple Agreements for Future Equity (SAFEs) into Series A Preferred Units
false
14
120000
true
0
Contingent fees subject to investment by referred investors
0
false
Next Frontier Biosciences, LLC
Marc Graboyes
Marc Graboyes
Manager
2017-05-24